OXLC | XFLT | OXLC / XFLT | |
Gain YTD | -18.259 | -9.293 | 196% |
Net Assets | 1.83B | 460M | 398% |
Total Expense Ratio | 12.45 | 4.24 | 294% |
Turnover | 21.57 | 50.00 | 43% |
Yield | 26.15 | 15.84 | 165% |
Fund Existence | 15 years | 8 years | - |
OXLC | XFLT | |
---|---|---|
RSI ODDS (%) | 3 days ago90% | 4 days ago88% |
Stochastic ODDS (%) | 3 days ago90% | 3 days ago90% |
Momentum ODDS (%) | 3 days ago65% | 3 days ago74% |
MACD ODDS (%) | 3 days ago71% | 3 days ago71% |
TrendWeek ODDS (%) | 3 days ago75% | 3 days ago75% |
TrendMonth ODDS (%) | 3 days ago78% | 3 days ago88% |
Advances ODDS (%) | 28 days ago89% | 26 days ago89% |
Declines ODDS (%) | 4 days ago76% | 4 days ago74% |
BollingerBands ODDS (%) | 3 days ago90% | 3 days ago85% |
Aroon ODDS (%) | 3 days ago87% | 3 days ago74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PVIVX | 49.42 | 0.70 | +1.44% |
Paradigm Micro-Cap | |||
ASVDX | 10.25 | 0.07 | +0.69% |
American Century Small Cap Value R6 | |||
VSMPX | 286.40 | 1.25 | +0.44% |
Vanguard Total Stock Mkt Idx Instl Pls | |||
GILLX | 23.90 | 0.10 | +0.42% |
Goldman Sachs Enhanced U.S. Equity Inst | |||
FBTAX | 28.16 | 0.01 | +0.04% |
Fidelity Advisor Biotechnology A |